Skip to main content
E

EDX Medical Group Plc — Investor Relations & Filings

Ticker · EDX ISIN · GB00BNDMJS47 LEI · 213800BZVJZTMCZ6DJ63 Aquis Stock Exchange Human health and social work activities
Open in API
Filings indexed 112 across all filing types
Latest filing 2026-04-21 Director's Dealing
Country GB United Kingdom
Listing Aquis Stock Exchange EDX

About EDX Medical Group Plc

https://edxmedical.com/

EDX Medical Group Plc develops and provides digital diagnostic products and services for healthcare professionals. Its solutions are designed for the rapid detection and characterization of major diseases, enabling personalized treatment and improved patient outcomes. The company's primary focus areas are oncology, cardiology, and infectious diseases. Key offerings in oncology include comprehensive tumour profiling using whole exome and transcriptome sequencing, liquid biopsy analysis, and functional ex vivo assays that predict tumour response to specific therapies. The company also develops highly sensitive tests for early detection of cancers such as prostate and testicular cancer. In infectious diseases, EDX Medical develops point-of-care multiplex tests for conditions like sepsis and pneumonia. The company's approach integrates advanced molecular biology, genomic sequencing, and digital technologies across its laboratory-based services and point-of-care devices.

Recent filings

Filing Released Lang Actions
Granting of options over ordinary shares
Director's Dealing Classification · 1% confidence The document is an RNS announcement detailing the grant of share options to directors and senior management, with PDMR tables specifying names, roles, ISIN, volumes, and transaction dates. This is a disclosure of insider dealings by directors (option grants). It is not an annual or quarterly report, nor a dividend or capital raise, but a director share transaction disclosure. Therefore it should be classified as Director's Dealing (DIRS).
2026-04-21 English
Proposed application for admission to AIM
Delisting Announcement Classification · 1% confidence The document is an RNS notice announcing the company’s simultaneous application for admission to trading on AIM and withdrawal of its shares from the Aquis Stock Exchange. It is not an earnings release, annual report, or management discussion but a formal regulatory announcement of a listing change (i.e., delisting from one exchange). This matches the definition of a Delisting Announcement (DLST).
2026-04-13 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an RNS announcement titled “Total Voting Rights,” providing the current number of ordinary shares and voting rights in issue under FCA Disclosure and Transparency Rules. This is a voting rights announcement rather than a financial report or management change. Therefore it fits the “Declaration of Voting Results & Voting Rights Announcements” category (Code: DVA).
2026-04-01 English
Scottish Prostate Cancer Initiative
Regulatory Filings Classification · 1% confidence The document is a corporate RNS press release announcing operational news (a partnership for a medical initiative) with no financial results, share transactions, governance changes, or report attachments. It does not fit any specific financial report or announcement types, so it falls under the general Regulatory Filings category (RNS).
2026-03-25 English
Exercise of Warrants
Share Issue/Capital Change Classification · 1% confidence The document is an announcement from EDX Medical Group plc regarding the exercise of warrants, which results in the issuance of new ordinary shares. This falls under the category of capital changes or share issues. According to the provided definitions, 'SHA' (Share Issue/Capital Change) is the appropriate classification for announcements regarding new share issues or capital changes.
2026-03-04 English
Total voting rights
Regulatory Filings Classification · 1% confidence The document is a formal announcement regarding 'Total Voting Rights' issued by EDX Medical Group PLC. It specifies the total number of ordinary shares in issue and the associated voting rights, which is a standard regulatory requirement under the Financial Conduct Authority's Disclosure and Transparency Rules. This type of filing is a routine regulatory disclosure and does not fit into specific categories like M&A, dividends, or financial reports. Therefore, it is classified as a Regulatory Filing (RNS).
2026-02-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.